StabiLux Biosciences

Ann Arbor, MI · Founded 2014 · Privately Held (backing)

Developer of high-brightness fluorophores designed to improve the reagents that run through flow cytometers. StabiLux Biosciences is based in Ann Arbor, MI and was founded in 2014. It has raised $1.9 million across 1 recorded round; the latest was a $554,381 seed round in Apr 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$1.9M
Last round
Seed Round
Apr 2024

Who backs StabiLux Biosciences?

12 investors
InvestorType
US National Science FoundationOther
Invest Detroit VenturesVenture capital
Lateral Capital ManagementVenture capital
Michigan Economic DevelopmentOther
Alligator Holdings—
Ann Arbor SPARK—
Cantilever Investors—
Invest Michigan—
John Lilly Strategic Insights—
MGS Mfg. Group—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

StabiLux Biosciences investors

12 investors are on record for StabiLux Biosciences, including US National Science Foundation, Invest Detroit Ventures, Lateral Capital Management and Michigan Economic Development. The seed round in Apr 2024 drew 9 investors.

Free account
More of StabiLux Biosciences with a free account
  • ·The complete investor list: 12 names
  • ·Watch StabiLux Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like StabiLux Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View